aminopterin has been researched along with Cancer of Skin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, A; Kobashi, H; Kusume, E; Nakajima, H; Oguro, T; Sano, H; Sano, S; Teraishi, M; Yamamoto, M | 1 |
| Cannell, P; Creeper, KJ; Frederiks, AJ; Radeski, D; Spagnolo, DV | 1 |
| Foss, FM; Girardi, M; Li, A; Parker, TL | 1 |
| Imataki, O; Kadowaki, N; Uchida, S; Uemura, M; Yokokura, S | 1 |
| Desai, N; Goff, HW; Rizvi, S; Stewart, JR; Zhu, H | 1 |
| Kerdel, FA; Maini, A; Styperek, AR | 1 |
| Wood, GS; Wu, J | 1 |
| Gilreath, JA; Halwani, AS; McPherson, JP; Sedillo, C; Vrontikis, A | 1 |
| Arranto, C; Halter, J; Tzankov, A | 1 |
| Horwitz, SM | 1 |
| Bartlett, NL; Delioukina, ML; Duvic, M; Fisher, DC; Foss, F; Horwitz, SM; Kim, YH; Koutsoukos, T; Lechowicz, MJ; Myskowski, PL; O'Connor, OA; Saunders, ME; Shustov, AR; Zain, JM | 1 |
| Berthelot, CN; Duvic, M; Jones, D; Leitenberger, JJ; McLaughlin, P; Polder, KD; Pro, B | 1 |
| Fanucchi, MP; Farag, F; Gralla, RJ; Kinahan, JJ; Kris, MG; Marks, LD; O'Connell, JP; Wertheim, MS; Williams, L; Young, CW | 1 |
3 review(s) available for aminopterin and Cancer of Skin
| Article | Year |
|---|---|
Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review.
Topics: Alemtuzumab; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Humans; Mycosis Fungoides; Retreatment; Sezary Syndrome; Skin Neoplasms | 2018 |
Methotrexate and Pralatrexate.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Apoptosis; DNA Methylation; Epigenesis, Genetic; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Methotrexate; S Phase; Skin Neoplasms | 2015 |
Novel therapies for cutaneous T-cell lymphomas.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Diphtheria Toxin; Folic Acid Antagonists; Histone Deacetylase Inhibitors; Humans; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Photopheresis; Recombinant Fusion Proteins; Skin Neoplasms; Tetrahydronaphthalenes | 2008 |
2 trial(s) available for aminopterin and Cancer of Skin
| Article | Year |
|---|---|
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antimetabolites, Antineoplastic; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Fatigue; Female; Gastrointestinal Diseases; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mucositis; Neutropenia; Salvage Therapy; Skin Neoplasms; Thrombocytopenia | 2012 |
Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.
Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Drug Evaluation; Half-Life; Humans; Neoplasms; Skin Neoplasms | 1988 |
8 other study(ies) available for aminopterin and Cancer of Skin
| Article | Year |
|---|---|
Pralatrexate for refractory mycosis fungoides in two Japanese patients.
Topics: Aminopterin; Humans; Japan; Mycosis Fungoides; Neoplasm Recurrence, Local; Skin Neoplasms | 2021 |
Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation.
Topics: Aminopterin; Antibiotics, Antineoplastic; Depsipeptides; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Mycosis Fungoides; Remission Induction; Skin Neoplasms; Treatment Outcome | 2021 |
Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate.
Topics: Aminopterin; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms | 2018 |
Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.
Topics: Adult; Aminopterin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
Clinical remission of primary aggressive CD8+ cutaneous T-cell lymphoma after pralatrexate infusion.
Topics: Aminopterin; Biopsy, Needle; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Time Factors; Treatment Outcome | 2014 |
Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions.
Topics: Aged; Aminopterin; Drug Interactions; Drug Monitoring; Folic Acid Antagonists; Furosemide; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Pleural Effusion; Reagent Kits, Diagnostic; Skin Neoplasms; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome | 2016 |
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Agents; Dendritic Cells; Humans; Male; Myeloproliferative Disorders; Recurrence; Skin Neoplasms; Time Factors; Treatment Outcome | 2017 |
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Dendritic Cells; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine; Vitamin B 12 | 2008 |